Biotech entity
Every one of those 1 sits in a single category, pharma. Rebecca Delaney is most often covered alongside Colorado, which appears in 1 of these 1 story. Rebecca Delaney appears in 1 tracked Biotech story from August 9, 2026. The tracked stories average 2 original sources each.
Last mentioned: Aug 9, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Rebecca Delaney is most often covered alongside Colorado, which appears in 1 of these 1 story. Rebecca Delaney appears in 1 tracked Biotech story from August 9, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 6 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Rebecca Delaney. Shared-story counts are live from our verified record — not editorial picks.
A University of Utah study of 170 seniors over 60 reveals a growing preference for cannabis over prescription drugs for pain and sleep, challenging the $30B+ analgesic market. The findings underscore unmet clinical demand and the need for FDA-approved cannabinoid therapies.
Rebecca Delaney is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
